Una Health is proud to announce its exclusive partnership as the UK distributor for the Lepzi® PLGF Test, a groundbreaking advancement in women’s healthcare. This next-generation point-of-care test offers rapid and reliable assessment for the diagnosis and prognosis of pre-eclampsia, a potentially life-threatening condition affecting pregnant women.

Pre-eclampsia is a disorder characterised by high blood pressure and signs of damage to other organ systems, often the liver and kidneys, typically developing after 20 weeks of pregnancy. Early detection is crucial to manage and mitigate risks to both mother and child. The Lepzi® PLGF Test measures Placental Growth Factor (PLGF) levels directly from EDTA- whole blood or plasma samples, aiding diagnosis and prognosis of pre-eclampsia.

Key Features of the Lepzi® PLGF Test:

• Rapid Results: Delivers quantitative PLGF measurements in just 15 minutes, facilitating prompt clinical decisions.
• User-Friendly Procedure: Requires only a 200µL whole blood sample. The process involves three simple steps: adding the sample to the cartridge, inserting the cartridge into the Lepzi® Reader, and reading the results displayed on-screen or printing a hard copy.
• No Centrifugation Needed: Streamlines the testing process by eliminating the need for laboratory-based sample preparation, making it ideal for point-of-care settings.
• Comparable Performance: Demonstrates performance comparable to tests recommended by the National Institute for Health and Care Excellence (NICE), ensuring high standards of accuracy and reliability.
• UKCA Marked: Meets UK regulatory requirements, affirming its safety and efficacy for clinical use.

The Lepzi® PLGF Test is compatible with the Lepzi® Reader, a portable fluorescence immunoassay reader designed for ease of use in various clinical environments. This platform allows healthcare professionals to obtain fast and reliable measurements, enhancing patient care by enabling timely intervention.

This partnership marks a significant milestone in Una Health’s commitment to bringing innovative diagnostic solutions in Women’s Health to the UK. By facilitating early detection and management of pre-eclampsia, the Lepzi® PLGF Test has the potential to improve maternal and fetal health outcomes across the country.

Meet the Lepzi® PLGF Test

For rapid, reliable pre-eclampsia diagnosis in just 15 minutes

Find out more